ARQT Q4 2019 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$60,000

Operating Income

-$13M

Net Income

-$13M

EPS (Diluted)

$-0.33

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$455,000

Balance Sheet

Total Assets

$107M

Total Liabilities

$6M

Stockholders' Equity

$101M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$60,000	$0	—
Operating Income	-$13M	-$6M	-118.3%
Net Income	-$13M	-$6M	-124.4%